Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.78 HKD | -0.30% | -0.40% | -3.28% |
Apr. 16 | Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets | MT |
Apr. 10 | Chinese FDA Grants Marketing Approval for Shyndec Subsidiary's Drug Raw Materials | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.28% | 7.91B | |
+12.91% | 69.11B | |
+5.83% | 25.91B | |
+5.02% | 8.01B | |
-27.52% | 7.27B | |
-0.67% | 4.51B | |
+21.54% | 4.48B | |
-2.45% | 3.95B | |
-3.99% | 3.79B | |
+23.90% | 3.7B |
- Stock Market
- Equities
- 1099 Stock
- News Sinopharm Group Co. Ltd.
- Sinopharm : China National Accord Medicines' 2020 Net Profit Rises Nearly 11%